Romidepsin Patent Expiration
Romidepsin was first introduced by Bristol-Myers Squibb Co
Romidepsin Patents
Given below is the list of patents protecting Romidepsin, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Istodax | US7608280 | Method of producing FR901228 |
Aug 22, 2021
(Expired) | Bristol-myers |
| Istodax | US7611724 | Method of producing FR901228 |
Aug 22, 2021
(Expired) | Bristol-myers |
| Istodax | US4977138 | FR901228 substance and preparation thereof |
Aug 22, 2013
(Expired) | Bristol-myers |
Romidepsin's Family Patents
Explore Our Curated Drug Screens
Romidepsin Generic API Manufacturers
Only one generic application has been filed for Romidepsin.
Given below is the list of companies who have filed for Romidepsin generic, along with the locations of their manufacturing plants worldwide.
1. FRESENIUS KABI USA
Fresenius Kabi Usa Llc has filed for 1 generic for Romidepsin. Given below are the details of the strengths of this generic introduced by Fresenius Kabi Usa.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 10MG/VIAL | powder | Prescription | INTRAVENOUS | AP | Oct 12, 2021 |
Manufacturing Plant Locations New
Fresenius Kabi Usa's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Fresenius Kabi Usa as present at those locations.
| Country | City | Firm Name | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||||||||